
Opinion|Videos|July 25, 2024
Fusion-Based Biopsies in Active Surveillance
Author(s)Kyrollis Attalla, MD
Kyrollis Attalla, MD, describes the role of fusion-based biopsies in active surveillance for patients with prostate cancer and how this technology has improved monitoring and treatment strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Is there a role for fusion-based biopsies in active surveillance for patients with prostate cancer?
- How has this technology improved surveillance strategies and informed treatment and management decisions?
- How has this technology improved surveillance strategies and informed treatment and management decisions?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
3
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5















